trailing 12 month adjusted EBITDA is now $251,000,000 with a trailing 12 month adjusted EBITDA margin of 20.1%. With respect to cash flows and our balance sheet, cash flows from operations was $45,000,000 in the quarter and free cash flow was $34,000,000 During the quarter, we invested $11,000,000 on capital projects, which included $5,000,000 related to the previously mentioned facility modernization projects. We spent $12,000,000 on acquisitions, which was primarily a deposit for the Hexagon Regasco acquisition, which closed on June 3, and we paid $8,000,000 in dividends. We also received $43,000,000 in dividends from our unconsolidated JVs during the quarter, a 106% cash conversion rate on that equity income. For the full fiscal year, we spent approximately $19,000,000 in CapEx related to the facility modernization projects and we have about $60,000,000 remaining to spend on those projects, which will be spread out over the next 2 years and they're expected to be completed by early fiscal 2027.